Add to ORKGWe report the synthesis and evaluation of novel chelating agents for zirconium-89
Contains fulltext : 181624.pdf (Publisher’s version ) (Open Access)Immuno-positron...
Current directions in radiochemistry and nuclear medicine highlight the importance of Positron Emiss...
Herein, we report the synthesis of three new bifunctional heptadentate metal ion binding chelates de...
The radioisotope zirconium-89 has attracted attention in recent years as a candidate for clinical us...
Positron emission tomography (PET) is used for non-invasive high sensitivity molecular imaging to di...
Antibodies are attractive targeting vectors for positron emission tomography (PET) based imaging age...
The future of 89 Zr-based immuno-PET is reliant upon the development of new chelators with improved ...
*S Supporting Information ABSTRACT: Zirconium-89 is an effective radionuclide for antibody-based pos...
International audienceNuclear medicine has seen impressive growth in recent years. An important deve...
In this work, we designed, developed, characterized, and investigated a new chelator and its bifunc...
The interest in zirconium-89 (89Zr) as a positron-emitting radionuclide has grown considerably over ...
Metal-based radiopharmaceuticals are critical in nuclear medicine for non-invasive diagnosis and tre...
Zirconium-89 is one of the few radionuclides among positron emitters which have a relatively long ph...
Molecular imaging-and especially Positron Emission Tomography (PET)-is of increasing importance for ...
Zirconium-89 is an effective radionuclide for antibody-based positron emission tomography (PET) imag...
Contains fulltext : 181624.pdf (Publisher’s version ) (Open Access)Immuno-positron...
Current directions in radiochemistry and nuclear medicine highlight the importance of Positron Emiss...
Herein, we report the synthesis of three new bifunctional heptadentate metal ion binding chelates de...
The radioisotope zirconium-89 has attracted attention in recent years as a candidate for clinical us...
Positron emission tomography (PET) is used for non-invasive high sensitivity molecular imaging to di...
Antibodies are attractive targeting vectors for positron emission tomography (PET) based imaging age...
The future of 89 Zr-based immuno-PET is reliant upon the development of new chelators with improved ...
*S Supporting Information ABSTRACT: Zirconium-89 is an effective radionuclide for antibody-based pos...
International audienceNuclear medicine has seen impressive growth in recent years. An important deve...
In this work, we designed, developed, characterized, and investigated a new chelator and its bifunc...
The interest in zirconium-89 (89Zr) as a positron-emitting radionuclide has grown considerably over ...
Metal-based radiopharmaceuticals are critical in nuclear medicine for non-invasive diagnosis and tre...
Zirconium-89 is one of the few radionuclides among positron emitters which have a relatively long ph...
Molecular imaging-and especially Positron Emission Tomography (PET)-is of increasing importance for ...
Zirconium-89 is an effective radionuclide for antibody-based positron emission tomography (PET) imag...
Contains fulltext : 181624.pdf (Publisher’s version ) (Open Access)Immuno-positron...
Current directions in radiochemistry and nuclear medicine highlight the importance of Positron Emiss...
Herein, we report the synthesis of three new bifunctional heptadentate metal ion binding chelates de...